… in this analysis, eligible trials had to fulfill the following criteria (Appendix II): randomised-control
trial design; enrolling adult patients (≥18 years of age) with essential hypertension (no …

… Preliminary evidence indicates that valsartan has similar antihypertensive efficacy to another
angiotensin II antagonist, losartan, in patients with mild to moderate essential hypertension; …

… We also review its pharmacodynamics, including safety and tolerability; specificity of action;
and the … We then review the studies examining clinical efficacy and safety in hypertension. …

… 3430 were reviews. Rather than attempting to review this work, we will focus here on a few
key and emerging issues that we think are of interest to clinicians dealing with hypertensive …

… In conclusion, our meta-analysis suggests that angiotensin II receptor antagonists, calcium
… left ventricular mass in patients with essential hypertension, and that they are significantly …

… period in patients with essential hypertension who received lercanidipine 10 or 20 mg/day. …
animal models and in patients with essential hypertension with or without diabetes mellitus. …

… in patients with mild to moderate essential hypertension, with little influence on heart rate. …
for the management of mild to moderate essential hypertension either as monotherapy or in …

… in this review, although, it is important to note that, so far, there is no conclusive published
evidence demonstrating the efficacy of beraprost in patients with Raynaud’s phenomenon. …

… severe hypertension who are unresponsive to, or intolerant of, their current therapy. However,
with its novel mechanism of action, good efficacy … with essential hypertension in the future. …

… Acupuncture is widely used in the clinical treatment of essential hypertension (EH). This
overview is aimed at summarizing current systematic reviews of acupuncture for EH and …